Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome.

The incidence rates of clinical endpoint events during follow‐up were consistent between groups and did not reach statistical significance ( p > 0.05) for any event: bleeding events (4.41% vs. 3.38%), coronary revascularization (7.35% vs. 6.75%), dyspnea symptoms (18.38% vs. 18.44%), or all‐cause mortality (5.88% vs. 3.90%).

also in 111,027 other papers